tiprankstipranks
Trending News
More News >
Invion Ltd. (AU:IVX)
:IVX
Advertisement

Invion (IVX) Price & Analysis

Compare
3 Followers

IVX Stock Chart & Stats


Invion News

IVX FAQ

What was Invion Ltd.’s price range in the past 12 months?
Invion Ltd. lowest share price was AU$0.08 and its highest was AU$0.43 in the past 12 months.
    What is Invion Ltd.’s market cap?
    Invion Ltd.’s market cap is AU$8.20M.
      When is Invion Ltd.’s upcoming earnings report date?
      Invion Ltd.’s upcoming earnings report date is Aug 29, 2025 which is in 20 days.
        How were Invion Ltd.’s earnings last quarter?
        Currently, no data Available
        Is Invion Ltd. overvalued?
        According to Wall Street analysts Invion Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Invion Ltd. pay dividends?
          Invion Ltd. does not currently pay dividends.
          What is Invion Ltd.’s EPS estimate?
          Invion Ltd.’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Invion Ltd. have?
          Invion Ltd. has 85,415,800 shares outstanding.
            What happened to Invion Ltd.’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Invion Ltd.?
            Currently, no hedge funds are holding shares in AU:IVX

            Invion Stock Smart Score

            Company Description

            Invion Ltd.

            Invion Limited, a clinical-stage life-sciences company, researches and develops photodynamic therapy for the treatment of various cancers in Australia. The company is developing IVX-PDT, a photosensitizer agent to treat skin cancers, as well as solid cancers, including lung, prostrate, ovarian, and mesothelioma cancers. It has a research and development agreement with Hudson Institute of Medical Research to collaborate on a range of research and development projects for the Photosoft technology for the treatment of a range of cancers; and research agreement with Peter MacCallum Cancer Centre to undertake pre-clinical and in-vitro studies on Invion's IVX-PDT Photodynamic therapy for ano-genital cancers, including penile and anal cancer. The company was incorporated in 2000 and is headquartered in Melbourne, Australia.

            Invion (IVX) Earnings & Revenues

            Currently, no data available
            Please return soon. This page is being updated.
            Similar Stocks
            Company
            Price & Change
            Follow
            Elixinol Wellness
            Cann Group
            Ecofibre
            Epsilon Healthcare Limited
            Bod Australia Ltd

            Ownership Overview

            7.19%92.81%
            Mutual Funds
            ― Other Institutional Investors
            92.81% Public Companies and
            Individual Investors

            Options Prices

            Currently, No data available
            ---
            Popular Stocks
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis